In a remarkable feat of medical innovation after years of research, Institute of Applied Dermatology (IAD) in Kasargod, Kerala has been successfully providing surgery-free integrative medical treatment, combining modern medicine with ayurveda and allopathy, to patients suffering from Lymphedema and Lymphatic Filariasis across the globe.
Patients from the United States, Somalia and United Kingdom have undergone successful treatment at Institute of Applied Dermatology in the last many years. The integrative medicine developed by IAD Director Dr S R Narahari, who is an allopathic dermatologist, under the guidance of his mentor Professor Terence Ryan of Dermatology, Oxford University, United Kingdom, has brought hope to millions of people affected by Lymphedema and Lymphatic Filariasis.
In fact, the Institute of Applied Dermatology has become a centre of excellence to treat Lymphedema and Lymphatic Filariasis. While the institute has been recognised by Bill and Melinda Gates Foundation as a centre of excellence for Lymphedema treatment, Kerala government has recognised it as a centre for integrated medicine.
“Though we are situated in a remote place in Kasargod, Kerala, we have managed to overcome the challenges of limited resources and infrastructure, leveraging technology and dedicated healthcare professionals to extend our services to thousands of Lymphedema and Lymphatic Filariasis patients in India and across the world. Our new free treatment project funded by Bill and Melina Gates Foundation has enabled us to reach out to hundreds of Lymphedema and Lymphatic Filariasis patients in Uttar Pradesh and Bihar,” said Dr Narahari.
As per the details with IAD, they have successfully treated a maximum number of Lymphedema and Lymphatic Filariasis patients in Kerala (690) followed by Karnataka (462), Andhra Pradesh (325), Maharashtra (178) and Tamil Nadu (158). “We have treated Lymphedema and Lymphatic Filariasis patients from the Middle East, South East Asia, Europe and the US,” Dr Narahari added.
“Our integrative medicine has been a big relief to Lymphedema and Lymphatic Filariasis patients who have been facing lack of proper treatment,” Dr Narahari said adding that his team also harnessed telemedicine and teleconferencing technologies to connect with Lymphedema and Lymphatic Filariasis patients in remote corners. “Through these virtual consultations, we provide treatment plans and extend our medical support,” Dr Narahari said.
“After years of suffering, I am able to get a huge relief by availing treatment from IAD. The quality of my life has significantly improved with reduced swelling, pain and enhanced mobility,” said a 46-year-old Lymphatic Filariasis patient from Varanasi who has been suffering from filariasis from the age of 30.
(This article is part of our public health awareness campaign #Hoperenewed)
Be First to Comment